Matthew P Connor, MD
Assistant Professor of Clinical Medicine (Hematology-Oncology)
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12 South Pavilion
Philadelphia, PA 19104
3400 Civic Center Blvd
12 South Pavilion
Philadelphia, PA 19104
Office: 267-624-4512
Fax: 215-615-5888
Fax: 215-615-5888
Education:
BS (Biology )
Boston College , 2011.
MD (Medicine )
Roaslind Franklin University of Medicine & Science , 2018.
Permanent linkBS (Biology )
Boston College , 2011.
MD (Medicine )
Roaslind Franklin University of Medicine & Science , 2018.
Description of Clinical Expertise
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Immune Effector Cell Therapies, Allogeneic Stem Cell TransplantationSelected Publications
Connor MP, Barsouk A, Elghawy O, Lai C: Advancements in targeted therapies for acute myeloid leukemia. Curr Opin Pharmacol 87, April 2026.Kopmar NE, Gooley TA, Roloff GW, Zhang A, Aldoss I, Lin C, Bezerra E, Muhsen I, Jeyakumar N, Dykes KC, O'Connor T, Tang K, Chen EC, Connor M, Frey NV, Gordillo CA, Hilal T, Al Darobi AH, Hoeg RT, Irizarry Gatell VM, Valtis YK, Jackson CW, Kota VK, Koura D, Boccucci J, Guzowski C, Kumaran MV, Ladha A, Lee CJ, Majhail NS, Malik SA, Mathews J, Miller K, Moore J, Mountjoy L, O'Dwyer KM, Odstrcil Bobillo S, Oliai CH, Oluwole OO, Pradeep R, Othman T, Ramakrishnan A, Reshef R, Sasine J, Vasu S, Schwartz M, Shaughnessy P, Stefan M, Stock W, Sutherland KC, Tan V, Solh MM, Tracy S, Luskin M, Logan AC, Leonard JT, Hill L, Tsai SB, Advani AS, Ulrickson M, Bachanova V, Dholaria B, Park JH, Battiwalla M, Faramand R, Shah BD, Yaghmour G, Muffly LS, Cassaday RD: Toxicity of Brexucabtagene Autoleucel as a Standard Therapy for Adults with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia. Blood Immunol Cell Ther(100028), December 2025.
Logan A, Yalniz F, Zhang A, Miller K, Sutherland K, Jeyakumar N, Srinagesh H, Grunwald M, Kota V, Boccucci J, Ulrickson M, Al-Darobi A, Sasine J, Hill L, Muhsen I, Advani A, Aldoss I, Othman T, Sandhu K, Reshef R, Luskin M, Chen E, Lin C, Cassaday R, Kopmar N, Solh M, Lee C, Odstrcil Bobillo S, Tsai S, O'Connor T, Hilal T, Park J, Valtis Y, Vasu S, Bezerra E, Wang E, Leonard J, Tan V, O'Dwyer K, Moore J, McCauley R, Majhail N, Mountjoy L, Ramakrishnan A, Malik S, Battiwalla M, Shaughnessy P, Mathews J, Jamy O, Mohty R, Kumaran M, Hoeg R, Stock W, Roloff G, Oliai C, Lill G, Schwartz M, Koura D, Dykes K, Daunov M, Byrd K, Bachanova V, Tracy S, Grover P, Frey N, Connor M, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole O, Dholaria B, Faramand R, Muffly L: Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world. Blood 146(Supplement 1): 516, November 2025.
Connor M, Hwang W, Gill S, Perl A, Jordan Bruno X, Hossain N, Lai C, Loren A, Luger S, Matthews A, McCurdy S, Munshi P, Pratz K, Cervini A, McConville J, Shea J, Tongue C, Difilippo H, Kesselman J, Marshall A, Four M, Christensen S, Gonzalez V, Jadlowsky J, Plesa G, Siegel D, Leskowitz R, Fraietta J, Levine B, Porter D, Hexner E, June C, Svoboda J, Frey N: IL18-armored CAR T cells in relapsed/refractory B cell acute lymphoblastic leukemia. Blood 146(Supplement 1): 812, November 2025.
McCauley R, Zhang A, Kota V, Boccucci J, Grunwald M, Ulrickson M, Hill L, Muhsen I, Sasine J, Advani A, Aldoss I, Sandhu K, Reshef R, Luskin M, Lin C, Cassaday R, Kopmar N, Solh M, Odstrcil Bobillo S, Tsai S, Hilal T, Shah B, Faramand R, Park J, Valtis Y, Othman T, Vasu S, Bezerra E, Leonard J, Tan V, O'Dwyer K, Moore J, Jamy O, Mohty R, Kumaran M, Hoeg R, Stock W, Oliai C, Lill G, Schwartz M, Koura D, Dykes K, Logan A, Daunov M, Byrd K, Yalniz F, Frey N, Connor M, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole O, Al-Darobi A, Chen E, Lee C, O'Connor T, Dholaria B, Bachanova V, Tracy S, Srinagesh H, Miller K, Sutherland K, Majhail N, Mountjoy L, Malik S, Ramakrishnan A, Shaughnessy P, Mathews J, Wang E, Battiwalla M, Roloff G, Muffly L: CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel. Blood 146(Supplement 1): 2396, November 2025.
Leonard J, Ladha A, Faramand R, Roloff G, Valtis Y, Tan V, Miller K, Zhang A, Grunwald M, Kota V, Boccucci J, Ulrickson M, Al-Darobi A, Hill L, Muhsen I, Sasine J, Advani A, Sandhu K, Reshef R, Luskin M, Chen E, Lin C, Cassaday R, Kopmar N, Solh M, Lee C, Odstrcil Bobillo S, Tsai S, O'Connor T, Hilal T, Park J, Vasu S, Bezerra E, O'Dwyer K, Moore J, Wang E, McCauley R, Majhail N, Ramakrishnan A, Mountjoy L, Malik S, Battiwalla M, Shaughnessy P, Mathews J, Srinagesh H, Sutherland K, Jamy O, Mohty R, Kumaran M, Hoeg R, Oliai C, Lill G, Stock W, Schwartz M, Othman T, Koura D, Dykes K, Logan A, Daunov M, Byrd K, Yalniz F, Bachanova V, Tracy S, Grover P, Connor M, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole O, Dholaria B, Frey N, Muffly L, Shah B, Aldoss, I: KMT2Ar, but not other high-risk genetics, adversely impacts outcomes in adult patients with relapsed/refractory (R/R) Philadelphia chromosome negative B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel (Brexu-cel). Blood 146(Supplement 1): 3365, November 2025.
Svoboda J, Schuster S, Porter D, Cook M, Nasta SD, Landsburg D, Barta S, Ruella M, Chong E, Carter J, Thomas C, Tomasulo E, Frey N, Connor M, Shea J, Cervini A, McConville J, Tongue C, Four M, Marshall A, Hwang W, Leskowitz R, Gonzalez V, Christensen S, Plesa G, Siegel D, Jadlowsky J, Fraietta J, Levine B, Hexner E, June C: IL18-armored CAR T cells in patients with CLL/SLL and Richter's transformation after prior BTK inhibitor and venetoclax failure. Blood 146(Supplement 1): 2394, November 2025.
Valtis Y, Sandhu K, Faramand R, Zhang A, Miller K, Hill L, Muhsen I, Othman T, Luskin M, Chen E, Oliai C, Lill G, Cassaday R, Kopmar N, Logan A, Connor M, Hilal T, Park J, Solh M, Guzowski C, Leonard J, Tan V, Jeyakumar N, Srinagesh H, Kumaran M, Hoeg R, Koura D, Dykes K, Stock W, Irizarry Gatell V, Jackson C, Oluwole O, Dholaria B, O'Dwyer K, Moore J, Ulrickson M, Al-Darobi A, Byrd K, Tsai S, O'Connor T, Wang E, McCauley R, Jamy O, Mohty R, Roloff G, Sutherland K, Aldoss I, Shah B, Muffly L, Frey N: Patient characteristics, toxicity, and response after real world administration of obecabtagene autoleucel and brexucabtagene autoleucel for relapsed acute lymphoblastic leukemia: A rocca analysis. Blood 146(Supplement 1): 2715, November 2025.
Valtis YK, Lin C, Nemirovsky D, Devlin S, Rejeski K, Curran KJ, Wang X, Shah NN, Jeyakumar N, Miller K, Zhang A, Kota VK, Al Darobi AH, Muhsen I, Sasine J, Aldoss I, Advani AS, Reshef R, Chen EC, Kopmar N, Tsai SB, Hilal T, Shah BD, Faramand R, Solh MM, Tan V, Bezerra E, Battiwalla M, Ramakrishnan A, Mathews J, Shaughnessy P, Mountjoy L, Hoeg RT, Dykes KC, Logan AC, Kumaran MV, Schwartz M, Tracy S, Moore J, Bobillo SO, Frey NV, Connor M, Ladha A, Dholaria B, Sutherland K, Roloff GW, Muffly LS, Park JH, Nair M, Ulrickson M, Ahmed M, Othman T, Bacani S, Stefan M, Luskin M, Cassaday R, O'Connor T, Guzowski C, Gordillo L, Vasu S, Majhail N, Malik S, Oliai C, Koura D, Stock W, Bachanova V, O'Dwyer K, Lee C, Yaghmour G, Oluwole O: CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia. Blood Adv In Press, October 2025.
O'Connor TE, Lin C, Roloff GW, Zhang A, Miller K, Aldoss I, Kopmar NE, Dekker SE, Gupta VK, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed N, Sutherland K, Dykes KC, Ahmed M, Chen E, Zambrano H, Bradshaw D, Mercadal S, Schwartz M, Tracy S, Connor MP, Kubiak M, Mukherjee A, Majhail N, Battiwalla M, Mountjoy L, Malik SA, Mathews J, Shaughnessy P, Blunk B, Logan AC, Ladha A, Advani AS, Stefan M, Guzowski C, Hoeg RT, Hilal T, Moore J, O'Dwyer KM, Hill LC, Sasine J, Oliai C, Solh MM, Lee CJ, Kota VK, Koura D, Kumaran MV, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Pullarkat V, Bishop MR, Stock W, Cassaday RD, Shah BD, Faramand R, Muffly LS, Tsai SB, Dholaria B: The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Bone Marrow Transplant Online ahead of print, Aug 2025.